Tyler R. Simpson - Concepedia

Author

Tyler R. Simpson

Memorial Sloan Kettering Cancer Center

Also Known As

T. Simpson, Tyler R Simpson, Tyler R. Simpson, Tyler Simpson, Tyler R. Simpson

Publications

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center The University of Texas MD Anderson Cancer Center Howard Hughes Medical Institute Juntendo University

About

Tyler R. Simpson is an author at Memorial Sloan Kettering Cancer Center specializing in immunology, medicine, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	3K
2	Immunology	6	6	3K
3	Cell Biology	4	4	343
4	Allergy	1	1	40
5	Pathology	1	1	2.5K

Tyler R. Simpson

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival Berna C. Özdemir, Tsvetelina Pentcheva‐Hoang, Julienne L. Carstens, Cancer Cell Pancreatic CancerMedicineAccelerates Pancreas CancerImmunologyReduced Survival	2014	2.5K
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma Tyler R. Simpson, Fubin Li, Welby Montalvo-Ortiz, The Journal of Experimental Medicine	2013	1.4K
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts Sergio A. Quezada, Tyler R. Simpson, Karl S. Peggs, The Journal of Experimental Medicine	2010	857
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma Sergio A. Quezada, Karl S. Peggs, Tyler R. Simpson, The Journal of Experimental Medicine T-regulatory CellImmunologyTherapeutic ActivityImmunoeditingRegulatory T Cells	2008	212
Innate Immune Activation and CD4+ T Cell Priming during Respiratory Fungal Infection Amariliz Rivera, Grace Ro, Heather L. Van Epps, Immunity InflammationRespiratory Fungal InfectionAdaptive Immune SystemInnate Immune SystemImmunology	2006	135
Cytotoxic T Lymphocyte Antigen-4 Blockade Enhances Antitumor Immunity by Stimulating Melanoma-Specific T-cell Motility Tsvetelina Pentcheva‐Hoang, Tyler R. Simpson, Welby Montalvo-Ortiz, Cancer Immunology Research T-regulatory CellImmunologyImmune RegulationImmunodominanceImmunoediting	2014	79
ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models Amanda Hanson, Kutlu G. Elpek, Ellen Duong, PLoS ONE T-regulatory CellImmunologyImmunoeditingImmunologic MechanismAnti-tumor Immunity	2020	40
Efficacy of anti-ICOS agonist monoclonal antibodies in preclinical tumor models provides a rationale for clinical development as cancer immunotherapeutics Christopher J. Harvey, Kutlu G. Elpek, Ellen Duong, Journal for ImmunoTherapy of Cancer Adaptive Immune SystemImmunologyImmunotherapeuticsImmunotherapyT Cells	2015	12
Multiple Fuel Injection Strategies for Compression Ignition Engines Tyler R. Simpson, Christopher Depcik Energies	2022	10

Page 1